Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZPR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPS12 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TSG101 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB31 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LSG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NECAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MROH7-TTC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBPJ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TPD52L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTRH2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VPS13D - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFKBIE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MLLT11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TXNDC9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LYPLA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
STX16 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SYNRG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCDC22 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM162A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RRP8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on